New diabetes clinical trial: Effect of Sodium Glucose Transporter-2 (SGLT-2) Inhibitors on Liver Fibrosis in Patients With Type2 Diabetes and Chronic Liver Disease (F3 Fibrosis) Using Liver Fibroscan

Published on: July 13, 2023 at 11:00AM
Condition:   Type2diabetes
Intervention:  
Sponsors:   Diabetes Foundation, India;   National Diabetes Obesity and Cholesterol Foundation
Completed
https://ift.tt/0de3gl1